Good communication with all of the doctors on a patient’s team, including transplant teams, can help to address treatment-related concerns, particularly those related to checkpoint inhibitor therapy and concerns surrounding potential organ rejection, noted Christine Ko, MD, professor of dermatology and pathology at Yale University.